Effect of an employer-sponsored health and wellness program on medical cost and utilization

Population Health Management

Volumn 16, Issue 1, 2013, Pages 1-6

  Liu, Hangsheng ^a   Harris, Katherine M ^a   Weinberger, Sarah ^b   Serxner, Seth ^c   Mattke, Soeren ^a   Exum, Ellen ^d  

^a RAND CORPORATION   (United States)

^b Mercer LLC   (United States)

^c Mercer Human Resource Consulting   (United States)

^d PEPSICO INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CLINICAL EFFECTIVENESS; EMERGENCY WARD; EMPLOYER; FEMALE; HEALTH CARE COST; HEALTH CARE DELIVERY; HEALTH CARE MANAGEMENT; HEALTH CARE PLANNING; HEALTH CARE UTILIZATION; HEALTH PROGRAM; HOSPITAL ADMISSION; HUMAN; LIFESTYLE; MALE; WELLBEING;

ADULT; DISEASE MANAGEMENT; FEMALE; HEALTH BENEFIT PLANS, EMPLOYEE; HEALTH CARE COSTS; HEALTH PLANNING; HEALTH PROMOTION; HUMANS; MALE; MIDDLE AGED; PROGRAM EVALUATION; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84873814608     PISSN: 19427891     EISSN: 19427905     Source Type: Journal    
DOI: 10.1089/pop.2011.0108     Document Type: Article

References (25)

1. Teslik LH. Backgrounder: Healthcare costs and U.S. competitiveness. Available at: http://www.nytimes.com/cfr/world/slot1-20070514.html?pagewanted all. Accessed February 8, 2009.
2. Mercer Health and Benefits LLC. Mercer's 2007 National Survey of Employer Sponsored Health Plans. New York, NY: Mercer Health and Benefits LLC; 2008.
3. Kaiser Family Foundation. Summary of new health reform law. Available at: http://www.kff.org/healthreform/8061.cfm. Accessed May 26, 2010.
4. Nyman JA, Barleen NA, Dowd BE. A return-on-investment analysis of the health promotion program at the University of Minnesota. J Occup Environ Med 2009;51:54-65.
5. Mattke S, Serxner SA, Zakowski SL, Jain AK, Gold DB. Impact of 2 employer-sponsored population health management programs on medical care cost and utilization. Am J Manag Care 2009;15:113-120.
6. Serxner S, Gold D, Meraz A, Gray A. Do employee health management programswork?AmJ Health Promot 2009;23:1-8.
7. Aldana SG. Financial impact of health promotion programs: A comprehensive review of the literature. Am J Health Promot 2001;15:296-320.
8. Chapman LS. Meta-evaluation of worksite health promotion economic return studies: 2005 update. Am J Health Promot 2005;19:1-10.
9. Pelletier KR. A review and analysis of the clinical-and costeffectiveness studies of comprehensive health promotion and disease management programs at the worksite: 1998-2000 update. Am J Health Promot 2001;16:107-116.
10. Pelletier KR. A review and analysis of the clinical and costeffectiveness studies of comprehensive health promotion and disease management programs at the worksite: Update VI 2000-2004. J Occup Environ Med 2005;47:1051-1058.
11. Naydeck BL, Pearson JA, Ozminkowski RJ, Day BT, Goetzel RZ. The impact of the Highmark employee wellness programs on 4-year healthcare costs. J Occup Environ Med 2008;50:146-156.
12. Brown R, Peikes D, Chen A, Schore J. 15-site randomized trial of coordinated care in Medicare FFS. Health Care Financ Rev 2008;30:5-25.
13. Cromwell J, McCall N, Burton J. Evaluation of Medicare Health Support chronic disease pilot program. Health Care Financ Rev 2008;30:47-60.
14. Esposito D, Brown R, Chen A, Schore J, Shapiro R. Impacts of a disease management program for dually eligible beneficiaries. Health Care Financ Rev 2008;30:27-45.
15. Mattke S, Seid M, Ma S. Evidence for the effect of disease management: Is $1 billion a year a good investment? Am J Manag Care 2007;13:670-676.
16. Goetzel RZ, Dunn RL, Ozminkowski RJ, Satin K, Whitehead DA, Cahill K. Differences between descriptive and multivariate estimates of the impact of Chevron Corporation's health quest program on medical expenditures. J Occup Environ Med 1998;40:538-545.
17. Ozminkowski RJ, Dunn RL, Goetzel RZ, Cantor RI, Murnane J, Harrison M. A return on investment evaluation of the Citibank, NA, health management program. Am J Health Promot 1999;14:31-43.
18. Ozminkowski RJ, Ling D, Goetzel RZ, et al. Long-term impact of Johnson & Johnson's health & wellness program on health care utilization and expenditures. J Occup Environ Med 2002;44:21-29.
19. Serxner SA, Gold DB, Grossmeier JJ, Anderson DR. The relationship between health promotion program participation and medical costs: A dose response. J Occup Environ Med 2003;45:1196-1200.
20. Disease Management Association of America. Disease Management Association of America, Outcomes Guidelines Report Volume II. Washington, DC: Disease Management Association of America; 2007.
21. Bureau of Labor Statistics. Producer Price Indexes. Available at: http://data.bls.gov/PDQ/outside.jsp?survey pd. Accessed September 12, 2008.
22. Bertrand M, Duflo E, Mullainathan S. How much should we trust differences-in-differences estimates? Q J Econ 2004;119: 249-275.
23. Heckman J, Ichimura H, Smith J, Todd P. Characterizing selection bias using experimental data. Econometrica 1998; 66:1017-1098.
24. Stukel TA, Fisher ES, Wennberg DE, Alter DA, Gottlieb DJ, Vermeulen MJ. Analysis of observational studies in the presence of treatment selection bias: Effects of invasive cardiac management on AMI survival using propensity score and instrumental variable methods. JAMA 2007;297:278-285.
25. Akaike H. A new look at the statistical model identification. IEEE Trans Automat Contr 1974;19:716-723.